Sign in to continue:

Tuesday, January 27th, 2026

Renounceable Non-Underwritten Rights Issue of GS Holdings Limited – Key Investor Details

Key Points and Investor Actions:

  1. Rights Issue Overview:

    • GS Holdings Limited is offering a renounceable non-underwritten rights issue of up to 570,888,708 new ordinary shares at an issue price of S$0.015 per Rights Share. The ratio is two (2) Rights Shares for every one (1) existing ordinary share held as of the record date.
  2. Discount Information:

    • The issue price represents an 11.76% discount to the volume-weighted average price of S$0.017.
  3. Dates to Note:

    • Record Date: 11 September 2024, 5:00 p.m.
    • Last Date for Acceptance and Payment for Rights Shares: 30 September 2024.
    • Trading of Rights Shares Commencement: 8 October 2024.
  4. Actions for Shareholders:

    • Eligible shareholders can subscribe for their provisional allotments by the deadline of 30 September 2024.
    • Excess Rights Shares can also be applied for during the rights issue period.
  5. Allotment and Listing:

    • Rights Shares have been allotted and listed on SGX-ST on 8 October 2024, with trading commencing the same day.

Special Notes for Investors:

  • Foreign shareholders will not be entitled to participate in this rights issue unless they have provided an address in Singapore prior to the record date.
  • The Rights Shares rank pari passu with existing shares, except for any dividends or distributions declared before the rights issue.

Investors should be aware of these timelines and ensure their actions align with the key dates to maximize their benefits from the rights issue.

Leong Guan Holdings Limited Lists on SGX Catalist to Drive Global Expansion and Sustainable Growth 1

Leong Guan Holdings Limited Debuts on SGX Catalist: Key Insights for Investors Leong Guan Holdings Limited Debuts on SGX Catalist: Key Insights for Investors Overview and Listing Details Leong Guan Holdings Limited (“Leong Guan”)...

Clearbridge Health Announces Key Dates for 1.28 Billion Share Rights Issue

Clearbridge Health’s Strategic Rights Issue: A Closer Look at Shareholder Opportunities Clearbridge Health’s Strategic Rights Issue: A Closer Look at Shareholder Opportunities Clearbridge Health Limited has announced a proposed renounceable non-underwritten rights issue, aiming...

Keppel REIT Raises S$113 Million via Private Placement; New Units Priced at S$0.983 Each and 3x Covered 12

Keppel REIT’s S\$113 Million Private Placement Draws Strong Global Demand: What Investors Need to Know Keppel REIT’s S\$113 Million Private Placement Draws Strong Global Demand: What Investors Need to Know Key Highlights from the...